Explore the words cloud of the MOGLYNET project. It provides you a very rough idea of what is the project "MOGLYNET" about.
The following table provides information about the project.
UNIVERSITA DEGLI STUDI DI MILANO
|Coordinator Country||Italy [IT]|
|Total cost||3˙086˙435 €|
|EC max contribution||3˙086˙435 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2015-09-01 to 2019-08-31|
Take a look of project's partnership.
|1||UNIVERSITA DEGLI STUDI DI MILANO||IT (MILANO)||coordinator||1˙032˙245.00|
|2||THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN||UK (ABERDEEN)||participant||546˙575.00|
|3||ACADEMISCH ZIEKENHUIS LEIDEN||NL (LEIDEN)||participant||510˙748.00|
|4||UNIVERSITEIT ANTWERPEN||BE (ANTWERPEN)||participant||501˙120.00|
|5||UNIVERSITAT DE BARCELONA||ES (BARCELONA)||participant||495˙745.00|
|7||BIOMAX INFORMATICS AG||DE (PLANEGG)||partner||0.00|
|9||HistoGeneX N.V.||BE (Berchem)||partner||0.00|
|10||KEMOTECH SRL||IT (PULA)||partner||0.00|
|11||LINKCARE HEALTH SERVICES SL||ES (BARCELONA)||partner||0.00|
|13||PPD||IT (Segrate Milano)||partner||0.00|
The mission of MoGlyNet is to define a joint doctorate educational training model in Drug Discovery and Development where Academia and Industry join their forces for: - creating a common platform of knowledge and language for early stage researchers (ESR) working in the Drug Discovery and Development area aiming to convey complementary pharma-skills - exploiting this platform to train a new generation of cutting-edge researchers and professionals highly attractive for employment by the European Pharma-industry - establishing structures for long-term cooperation, strengthening the relationships among the leading Universities and Pharma-enterprises and to continuously develop the research training platform that European industry relies on. To achieve the above objectives the main tasks of MoGlyNet are: - to attract/train 12 ESRs in optimization joint academic/industrial program of cutting-edge training-by-research, high quality supervision, complementary and transferable Pharma-skills training, inter-network secondments, and workshops/Summer Schools - to pursue an innovative research project that will tackle a timely and important scientific problem with a multidisciplinary approach (from molecular modelling to in vivo studies). Atherosclerosis is an aging-related disease and our research approach for a better therapy of atherosclerosis will be focused on the PFKFB3 enzyme, a key player in glycolysis/oxidative stress and therefore in pathological angiogenesis - to build a solid foundation for long-term European excellence in this field by disseminating MoGlyNet research/training outcomes and best practice into the partners Doctoral Schools, and by fostering long-term partnerships and collaborations that will outlast the Consortium - to transfer expertise/know-how among the Consortium participants and to external groups via networking activities, intersectorial exposure, secondments, workshops, sharing of learning material, public engagement and outreach activities
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOGLYNET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MOGLYNET" are provided by the European Opendata Portal: CORDIS opendata.
Open Ground Truth Training Network : Magnetic resonance image simulationfor training and validation of image analysis algorithmsRead More
Hybrid Fibre-reinforced composites: achieving Synergetic effects through microstructural design and advanced simulation toolsRead More
Quantitative T cell Immunology and ImmunotherapyRead More